Impact of pharmacokinetic (CYP2C9) and pharmacodynamic (VKORC1, F7, GGCX, CALU, EPHX1) gene variants on the initiation and maintenance phases of phenprocoumon therapy
| Image |  |
|---|---|
| Description | scientific article published on 05 November 2010 |
| Author/s |
author: Johannes Oldenburg |
| Publication date | November 5, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |